About
ExPLoRNA Therapeutics develops innovative mRNA technology platforms and novel cap analogs to improve the synthesis and efficacy of mRNA vaccines and therapeutics, collaborating with pharmaceutical partners.
Explore ExPLoRNA Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.